You are here: Industry Insights > Pfizer

News List

Pfizer secures EC approval for oral PARP inhibitor Talzenna pharmaceutical-technology
June 26, 2019
Pfizer has secured approval from the EC for Talzenna (talazoparib) as a monotherapy to treat adult patients with germline breast cancer with gBRCA gene mutations.
Manufacturing of paediatric medicines set to improve with new investments europeanpharmaceuticalreview
June 24, 2019
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
Pfizer to buy Array Biopharma for $10.64 bn in cash expresspharma
June 21, 2019
Pfizer will buy Array Biopharma for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
Pfizer to improve paediatric medicines manufacturing pharmaceutical-technology
June 21, 2019
Pfizer is set to make an investment in its Discovery Park site in Sandwich, Kent, UK.
Pfizer announces results from Xeljanz® Xr oral shift study biospectrumasia
June 19, 2019
Results to be Presented During a Late-Breaking Oral Session at the Annual European Congress of Rheumatology (EULAR 2019)
Pfizer to acquire US company Array BioPharma for $11.4bn pharmaceutical-technology
June 19, 2019
Pfizer has signed a definitive merger agreement to acquire US-based, commercial-stage biopharmaceutical company Array BioPharma.
Pfizer to acquire Array BioPharma in a $11.4B deal biospectrumasia
June 18, 2019
Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term
Pfizer to Acquire Array BioPharma for $11.4B contractpharma
June 18, 2019
Expands innovative biopharma business with multiple targeted investigational cancer therapies and adds a large portfolio of royalty-generating medicines.
Sosei Heptares to get $3m Pfizer milestone payment pharmatimes
June 11, 2019
Sosei Heptares has announced that it is to receive a new $3 million milestone payment from its strategic alliance partner Pfizer, as it advances a second candidate from the GPCR collaboration for clinical development.
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development worldpharmanews
June 10, 2019
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page